| International Myeloma Working Group molecular classification of multiple myeloma: spotlight review R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ... Leukemia 23 (12), 2210-2221, 2009 | 1178 | 2009 |
| Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ... Leukemia 26 (1), 149-157, 2012 | 1006 | 2012 |
| Genetics and cytogenetics of multiple myeloma: a workshop report R Fonseca, B Barlogie, R Bataille, C Bastard, PL Bergsagel, M Chesi, ... Cancer research 64 (4), 1546-1558, 2004 | 931 | 2004 |
| In multiple myeloma, t (4; 14)(p16; q32) is an adverse prognostic factor irrespective of FGFR3 expression JJ Keats, T Reiman, CA Maxwell, BJ Taylor, LM Larratt, MJ Mant, ... Blood, The Journal of the American Society of Hematology 101 (4), 1520-1529, 2003 | 495 | 2003 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 433 | 2016 |
| In Vitro and in Vivo Targeting of Immunoliposomal Doxorubicin to Human B-Cell Lymphoma DE Lopes de Menezes, LM Pilarski, TM Allen Cancer research 58 (15), 3320-3330, 1998 | 420 | 1998 |
| The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer LH Regimbald, LM Pilarski, BM Longenecker, MA Reddish, ... Cancer research 56 (18), 4244-4249, 1996 | 294 | 1996 |
| Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group J Laubach, L Garderet, A Mahindra, G Gahrton, J Caers, O Sezer, ... Leukemia 30 (5), 1005-1017, 2016 | 288 | 2016 |
| Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event. HM Serra, JF Krowka, JA Ledbetter, LM Pilarski Journal of immunology (Baltimore, Md.: 1950) 140 (5), 1435-1441, 1988 | 269 | 1988 |
| RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability CA Maxwell, JJ Keats, M Crainie, X Sun, T Yen, E Shibuya, M Hendzel, ... Molecular biology of the cell 14 (6), 2262-2276, 2003 | 248 | 2003 |
| In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears … PL Bergsagel, AM Smith, A Szczepek, MJ Mant, AR Belch, LM Pilarski | 224 | 1995 |
| Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer S Adamia, CA Maxwell, LM Pilarski Current Drug Targets-Cardiovascular & Hematological Disorders 5 (1), 3-14, 2005 | 222 | 2005 |
| Overexpression of transcripts originating from the MMSET locus characterizes all t (4; 14)(p16; q32)-positive multiple myeloma patients JJ Keats, CA Maxwell, BJ Taylor, MJ Hendzel, M Chesi, PL Bergsagel, ... Blood 105 (10), 4060-4069, 2005 | 199 | 2005 |
| A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells EG Cen, C Dalton, Y Li, S Adamia, LM Pilarski, KVIS Kaler Journal of microbiological methods 58 (3), 387-401, 2004 | 189 | 2004 |
| Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice LM Pilarski, G Hipperson, K Seeberger, E Pruski, RW Coupland, ... Blood, The Journal of the American Society of Hematology 95 (3), 1056-1065, 2000 | 179 | 2000 |
| A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single … AJ Szczepek, K Seeberger, J Wizniak, MJ Mant, AR Belch, LM Pilarski Blood, The Journal of the American Society of Hematology 92 (8), 2844-2855, 1998 | 179 | 1998 |
| CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications SP Treon, LM Pilarski, AR Belch, A Kelliher, FI Preffer, Y Shima, ... Journal of immunotherapy 25 (1), 72-81, 2002 | 174 | 2002 |
| Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone SP Treon, JA Mollick, M Urashima, G Teoh, D Chauhan, A Ogata, N Raje, ... Blood, The Journal of the American Society of Hematology 93 (4), 1287-1298, 1999 | 170 | 1999 |
| A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors. LM Pilarski The Journal of experimental medicine 145 (3), 709-725, 1977 | 168 | 1977 |
| Monoclonal circulating B cells in multiple myeloma: a continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules LM Pilarski, GS Jensen Hematology/oncology clinics of North America 6 (2), 297-322, 1992 | 164 | 1992 |
Sophia Adamia, PhDInstructor in Medicine, Dana-Farber cancer Institute & HMSE-mail confirmado em dfci.harvard.edu
